Learn more about targeted radiopharmaceutical therapy and the mechanism of action of radiotherapeutic agents used for the treatment of tumors expressing specific receptors on their surface.

Somatostatin signaling is an important pathway involved in the pathophysiology of neuroendocrine tumors (NETs) that allows a personalized theranostic approach to their management.

Learn more about targeted radiopharmaceutical therapy and the mechanism of action of radiotherapeutic agents used for the treatment of tumors expressing specific receptors on their surface.

Find out the difference between the production of carrier-added versus non-carrier-added lutetium-177, a radioisotope of choice for targeted radiopharmaceutical therapy.

Most medical-grade radionuclides used in synthesizing diagnostic and therapeutic radiopharmaceuticals are produced through one of the four methods of nuclear activation: fission, neutron activation, cyclotron and generator systems. Find out more in the infographic.​